About Diaceutics
Diaceutics is a company based in Belfast (United Kingdom) founded in 2005.. The company has 199 employees as of December 31, 2024. Diaceutics offers products and services including DXRX Network, DXRX Data Solutions, and DXRX Signal. Diaceutics operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others.
- Headquarter Belfast, United Kingdom
- Employees 199 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Diaceutics Plc
-
Annual Revenue
$40.29 M (USD)35.69as on Dec 31, 2024
-
Net Profit
$-2.13 M (USD)2.46as on Dec 31, 2024
-
EBITDA
$2.92 M (USD)13.38as on Dec 31, 2024
-
Latest Funding Round
$26.14 M (USD), Post-IPO
Jun 11, 2020
-
Investors
SVB
& 1 more
-
Employee Count
199
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Diaceutics
Diaceutics is a publicly listed company on the LSE with ticker symbol DXRX in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Diaceutics
Diaceutics offers a comprehensive portfolio of products and services, including DXRX Network, DXRX Data Solutions, and DXRX Signal. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Facilitates collaboration for precision medicine stakeholders.
Provides access to real-world diagnostic testing data pipelines.
Links rare disease patients to targeted therapies efficiently.
Unlock access to complete
Unlock access to complete
Funding Insights of Diaceutics
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $26.1M
-
First Round
First Round
(05 Apr 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Post-IPO - Diaceutics | Valuation |
investors |
|
| Apr, 2018 | Amount | Debt – Venture - Diaceutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Diaceutics
Diaceutics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB and Whiterock Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt funding is provided across multiple sectors.
|
Founded Year | Domain | Location | |
|
Banking services are provided to innovative companies, investors, and individuals.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Diaceutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Diaceutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Diaceutics Comparisons
Competitors of Diaceutics
Diaceutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Suite solutions are provided for payers and healthcare providers.
|
|
| domain | founded_year | HQ Location |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| domain | founded_year | HQ Location |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| domain | founded_year | HQ Location |
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
|
| domain | founded_year | HQ Location |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| domain | founded_year | HQ Location |
Technology-based consultancy and product development services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Diaceutics
Frequently Asked Questions about Diaceutics
When was Diaceutics founded?
Diaceutics was founded in 2005 and raised its 1st funding round 13 years after it was founded.
Where is Diaceutics located?
Diaceutics is headquartered in Belfast, United Kingdom. It is registered at Belfast, Northern Ireland, United Kingdom.
How many employees does Diaceutics have?
As of Dec 31, 2024, the latest employee count at Diaceutics is 199.
What is the annual revenue of Diaceutics?
Annual revenue of Diaceutics is $40.29M as on Dec 31, 2024.
What does Diaceutics do?
Diaceutics Group acts as an integrator in the precision medicine space. The company uses analytics, software, services and consulting to enable integration of therapies and diagnostics into the treatment pathway. The companys services include strategic consulting; digital decision tools and training; laboratory test commercialization; and branding and communication of personalized medicine solutions. The Groups divisions include: Labceutics, Diaceutics AIS, Lceltics, and Bioceutics. It client list includes Novartis, Pfizer, Boehringer Ingelheim, MedImmune, AstraZeneca and Bristol Myers-Squibb, the Bill Melinda Gates Foundation and many more.
Who are the top competitors of Diaceutics?
Diaceutics's top competitors include Indegene, Zuellig Pharma and IntegriChain.
What products or services does Diaceutics offer?
Diaceutics offers DXRX Network, DXRX Data Solutions, and DXRX Signal.
Is Diaceutics publicly traded?
Yes, Diaceutics is publicly traded on LSE under the ticker symbol DXRX.
Who are Diaceutics's investors?
Diaceutics has 2 investors. Key investors include SVB, and Whiterock Finance.
What is Diaceutics's ticker symbol?
The ticker symbol of Diaceutics is DXRX on LSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.